HBM HOLDINGS-B (02142) announced that the company has been notified that its Independent Non-Executive Director, Dr. Ye Xiaoping, received an investigation notice from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notice pertains to alleged violations of information disclosure regulations related to shareholding changes in Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ; 3347.HK). In accordance with the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the CSRC has decided to initiate an investigation into Dr. Ye. Dr. Ye has stated he will fully cooperate with the CSRC's work and strictly fulfill information disclosure obligations as required by regulations. As an Independent Non-Executive Director, Dr. Ye is not involved in the day-to-day management or operations of the group. The company's board of directors believes the group's business operations remain normal and the aforementioned investigation will not affect the group's normal operations.